# K133725: Traxcess 14 Guidewire

- Pathway: 510(k) (Traditional)
- Applicant: MicroVention, Inc.
- Decided: Jul 31, 2014 after 237 days
- Product code: MOF (Guide, Wire, Catheter, Neurovasculature)
- Device class: 2
- Regulation: 21 CFR 870.1330
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K953533 (1995). 6 ancestors in all.
9 later devices descend from it; 4 cite it directly.
0 of 16 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K080863: Traxcess 0.014 Hydrophilic Guidewire, MicroVention, Inc. (2008) Summary page 1.

## Most influential descendants
- K153053: Traxcess Pro 14 Guidewire (2015), 4 descendants of its own
- K161803: Traxcess .007 Mini Guidewire (2016), 2 descendants of its own
- K182337: HYBRID Guidewire (2018), 1 descendant of its own
- K252317: Zenith Micro Guidewire (2026), 0 descendants of its own
- K252011: CHIKAI Nexus petit (2026), 0 descendants of its own

## Indications for use
The Traxcess 14 Guidewire is intended for general intravascular use, including the neuro and peripheral vasculature. The guidewire can be steered to facilitate the selective placement of diagnostic or therapeutic catheters. This device is not intended for use in coronary arteries.

Source page: https://510kreport.com/device/K133725
Methodology: https://510kreport.com/methodology